KR20070007030A - 신규한 다능성 줄기세포 및 그의 용도 - Google Patents

신규한 다능성 줄기세포 및 그의 용도 Download PDF

Info

Publication number
KR20070007030A
KR20070007030A KR1020067010523A KR20067010523A KR20070007030A KR 20070007030 A KR20070007030 A KR 20070007030A KR 1020067010523 A KR1020067010523 A KR 1020067010523A KR 20067010523 A KR20067010523 A KR 20067010523A KR 20070007030 A KR20070007030 A KR 20070007030A
Authority
KR
South Korea
Prior art keywords
cells
bone marrow
cell
implant
isolated
Prior art date
Application number
KR1020067010523A
Other languages
English (en)
Korean (ko)
Inventor
영섭 윤
더글라스 더블유. 로소르도
Original Assignee
카리타스 세인트 엘리자베스 메디칼 센터 오브 보스톤, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 카리타스 세인트 엘리자베스 메디칼 센터 오브 보스톤, 인코포레이티드 filed Critical 카리타스 세인트 엘리자베스 메디칼 센터 오브 보스톤, 인코포레이티드
Publication of KR20070007030A publication Critical patent/KR20070007030A/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020067010523A 2003-10-28 2004-10-28 신규한 다능성 줄기세포 및 그의 용도 KR20070007030A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51532003P 2003-10-28 2003-10-28
US60/515,320 2003-10-28

Publications (1)

Publication Number Publication Date
KR20070007030A true KR20070007030A (ko) 2007-01-12

Family

ID=34549391

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067010523A KR20070007030A (ko) 2003-10-28 2004-10-28 신규한 다능성 줄기세포 및 그의 용도

Country Status (7)

Country Link
EP (1) EP1685237A4 (zh)
JP (1) JP2007519397A (zh)
KR (1) KR20070007030A (zh)
CN (1) CN101072867A (zh)
AU (1) AU2004286322A1 (zh)
CA (1) CA2543794A1 (zh)
WO (1) WO2005042723A2 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009042173A1 (en) * 2007-09-24 2009-04-02 University Of South Florida Materials and methods for treating allergic and inflammatory conditions
KR20180055931A (ko) * 2009-10-30 2018-05-25 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 간외 담도계로부터의 다분화능 줄기 세포 및 이의 분리 방법

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090155220A1 (en) * 2005-10-20 2009-06-18 Caritas St. Elizabeth's Medical Center Of Boston Use of Bone-Marrow Derived Stem Cells to Treat Ischemia
CN103952373A (zh) * 2005-12-08 2014-07-30 路易斯维尔大学研究基金会有限公司 非常小的胚胎样(vsel)干细胞及分离和利用其的方法
US9155762B2 (en) 2005-12-08 2015-10-13 University Of Louisville Research Foundation, Inc. Uses and isolation of stem cells from bone marrow
AU2007243221A1 (en) * 2006-04-28 2007-11-08 Tulane University Health Sciences Center Methods for treating diabetes
US11312940B2 (en) 2015-08-31 2022-04-26 University Of Louisville Research Foundation, Inc. Progenitor cells and methods for preparing and using the same
WO2017152073A1 (en) 2016-03-04 2017-09-08 University Of Louisville Research Foundation, Inc. Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (vsels)
CN115369077B (zh) * 2022-07-29 2023-07-18 佛山市中科律动生物科技有限公司 Meflc细胞株及其构建方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2296704C (en) * 1997-07-14 2010-10-19 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US6291240B1 (en) * 1998-01-29 2001-09-18 Advanced Tissue Sciences, Inc. Cells or tissues with increased protein factors and methods of making and using same
US6328762B1 (en) * 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009042173A1 (en) * 2007-09-24 2009-04-02 University Of South Florida Materials and methods for treating allergic and inflammatory conditions
KR20180055931A (ko) * 2009-10-30 2018-05-25 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 간외 담도계로부터의 다분화능 줄기 세포 및 이의 분리 방법

Also Published As

Publication number Publication date
EP1685237A4 (en) 2007-12-26
CN101072867A (zh) 2007-11-14
WO2005042723A2 (en) 2005-05-12
WO2005042723A9 (en) 2005-08-18
AU2004286322A1 (en) 2005-05-12
WO2005042723A3 (en) 2007-03-29
CA2543794A1 (en) 2005-05-12
EP1685237A2 (en) 2006-08-02
JP2007519397A (ja) 2007-07-19

Similar Documents

Publication Publication Date Title
Yoon et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction
Invernici et al. Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia
Botta et al. Heart infarct in NOD‐SCID mice: Therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+ KDR+ cells
Moon et al. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia
US8623351B2 (en) Compositions comprising vascular and myocyte progenitor cells and methods of their use
US20040197310A1 (en) Compositions and methods for using umbilical cord progenitor cells in the treatment of myocardial infarction
US20100267107A1 (en) Methods for isolating very small embryonic-like (vsel) stem cells
US20120021482A1 (en) Methods for isolating very small embryonic-like (vsel) stem cells
US20080213235A1 (en) Adipose Tissue Stem Cells, Perivascular Cells and Pericytes
Suzuki et al. Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells
US8071380B2 (en) Skeletal muscle periangioblasts and cardiac mesangioblasts, method for isolation and uses thereof
JP2010535468A (ja) 心臓脂肪組織由来の成体幹細胞集団および心臓再生におけるその使用
Lu et al. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction
JP2023016915A (ja) ヒト心室前駆細胞を単離するための方法
Dupas et al. Fetal muscle contains different CD34+ cell subsets that distinctly differentiate into adipogenic, angiogenic and myogenic lineages
CN109152799B (zh) 胰腺干细胞及其用途
KR20070007030A (ko) 신규한 다능성 줄기세포 및 그의 용도
US20070253937A1 (en) Novel multipotent stem cells and use thereof
WO2007047963A2 (en) Use of bone-marrow derived stem cells to treat ischemia
Shibuya et al. Tongue muscle-derived stem cells express connexin 43 and improve cardiac remodeling and survival after myocardial infarction in mice
Emanueli et al. In search of the best candidate for regeneration of ischemic tissues
Al-Kindi et al. Cellular cardiomyoplasty: evidence of cellular therapy, mechanisms and controversies
Iwasaki et al. Cardiomyogenesis for Functional Regenerative Recovery After Myocardial Infarction
Pesce et al. UltraRapid Communication
Sabry Endothelial progenitor cells regenerate infracted myocardium with neovascularisation development 2

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid